Idéal Investisseur
Français English
CAC 40 : Market open
7 898,17 pts
-0.68%


Last updated : 18/05/2026 - 13h36
🏠 Home   ➤    Stock news

Emeis Shares Drop 3.8% Yet Maintain 40% Yearly Gain

Emeis shares fell by 3.76% to €14.57 by midday Monday, while the SBF 120 index dropped by 0.74%. Despite being among the largest declines in the index, the stock still shows a 40.77% increase over the past year amid global bond market tensions and Brent crude above $110.


Emeis Shares Drop 3.8% Yet Maintain 40% Yearly Gain

The Pullback Brings Emeis's Price to its 20-Day Moving Average

Following a session on May 14 at €15.25, which had brought the stock close to its resistance level at €15.33, Emeis has erased some of its gains, returning to €14.57. The price is now at the contact point of the 20-day moving average at €14.55, with a residual gap of 0.14%. This zone had served as a pivot in recent weeks. Longer averages remain favorably oriented: the 50-day MA at €14.04 is about 3.8% below the price, and the 200-day MA at €13.77 is nearly 5.8% lower. The RSI at 58 remains in neutral territory, away from overbought or oversold zones. The technical support identified at €13.39 marks the next lower boundary if the decline continues.

A Session Hampered by Bond Pressure and Global Oil Shock

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

Today's decline occurs in a deteriorated market environment. U.S. and Japanese sovereign yields are hitting new highs, with the U.S. 10-year reaching 4.63%, its highest since February 2025. Brent crude is trading around $111 per barrel, following the war in Iran and the prolonged closure of the Strait of Hormuz. Markets now estimate a more than 50% probability of a Fed rate hike by December. The CAC 40 is down 0.7% and the SBF 120 has lost 0.74%. In early May, the company confirmed its outlook when it published its first-quarter revenue, with organic growth of 6.3% and an expected EBITDAR guidance for 2026 to increase by more than 10%. The appointment of Jean-Marc Boursier as the new deputy CEO, effective July 1, rounds out the governance schedule. Over a year, the stock maintains a 40.77% lead.



Sector Santé · Etablissements de santé / EHPAD Etablissements de santé


Assurance vie

Context

Period
  • Period: 1T2026
Key reported figures
  • Revenue: 1509M€
Risks mentioned
  • Les mesures de qualité engagées en 2024 et 2025 sont essentielles.
  • La demande de lits devrait dépasser l'offre de 550 000 d'ici 2030.
Opportunities identified
  • Croissance organique de +6,3 % au 1T2026, soutenue par des taux d'occupation améliorés.
  • Réduction de la sensibilité aux pressions inflationnistes grâce à un hedging sur 90 % des dépenses énergétiques.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit